Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000238

EVP, Finance & CFO sold 49,800 shares at $65.26 ($3,249,734)

  • EVP, Finance & CFO acquired 49,800 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

HOUGEN ELIZABETH L · EVP, Finance & CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +49,800 $53.77 $2,677,746 160,300 D
2025-09-30 Sale : show line 2 in the form 10b5-1 −49,800 $65.26 $3,249,734 110,500 D
Open-market sales · 49,800 sh · avg $65.26 · $3,249,734

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −49,800 0 D
Loading xslF345X05/edgardoc.xml…